Top

Published in:

Open Access 01-11-2017 | Preclinical study

Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution

Authors: Melody L. Stallings-Mann, Ethan P. Heinzen, Robert A. Vierkant, Stacey J. Winham, Tanya L. Hoskin, Lori A. Denison, Aziza Nassar, Lynn C. Hartmann, Daniel W. Visscher, Marlene H. Frost, Mark E. Sherman, Amy C. Degnim, Derek C. Radisky

Published in: Breast Cancer Research and Treatment | Issue 1/2017

Abstract

Purpose

Breast terminal duct lobular units undergo two distinctive physiological processes of involution: age-related lobular involution (LI), which is gradual and associated with decreased breast cancer risk, and postlactational involution, which is relatively precipitous, occurs with weaning, and has been associated with potentiation of tumor aggressiveness in animal models. Here we assessed whether markers of postlactational involution are associated with ongoing LI in a retrospective tissue cohort.

Methods

We selected 57 women from the Mayo Clinic Benign Breast Disease Cohort who underwent multiple biopsies and who were average age 48 at initial biopsy. Women were classified as having progressive or non-progressive LI between initial and subsequent biopsy. Serial tissue sections were immunostained for plasminogen, matrix metalloproteinase 9 (MMP-9), phospho-STAT3 (pSTAT3), tenascin C, Ki67, CD44, cytokeratin 14 (CK14), cytokeratin 19 (CK19), and c-myc. All but Ki67 were digitally quantified. Associations between maximal marker expression per sample and progressive versus non-progressive LI were assessed using logistic regression and adjusted for potential confounders.

Results

While no biomarker showed statistically significant association with LI progression when evaluated individually, lower expression of pSTAT3 (OR 0.35, 95% CI 0.13–0.82, p = 0.01) and higher expression of plasminogen (OR 2.89, 95% CI 1.14–8.81, p = 0.02) were associated with progressive LI in models simultaneously adjusted for all biomarkers. Sensitivity analyses indicated that the strengthening in association for pSTAT3 and plasminogen with progressive LI was due to collinearity between these two markers.

Conclusions

This is the first study to identify biomarkers of active LI. Our findings that plasminogen and pSTAT3 are significantly associated with LI suggest that they may represent signaling nodes or biomarkers of pathways common to the processes of postlactational involution and LI.

Available only for authorised users

Hutson SW, Cowen PN, Bird CC (1985) Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer. J Clin Pathol 38(3):281–287CrossRefPubMedPubMedCentral

Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, Thompson RA, Melton LJ 3rd, Goode EL, Visscher DW (2006) Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 98(22):1600–1607. doi:10.1093/jnci/djj439 CrossRefPubMed

Radisky DC, Visscher DW, Frank RD, Vierkant RA, Winham S, Stallings-Mann M, Hoskin TL, Nassar A, Vachon CM, Denison LA, Hartmann LC, Frost MH, Degnim AC (2016) Natural history of age-related lobular involution and impact on breast cancer risk. Breast Cancer Res Treat 155(3):423–430. doi:10.1007/s10549-016-3691-5 CrossRefPubMedPubMedCentral

Watson CJ (2006) Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ. Breast Cancer Res 8(2):203. doi:10.1186/bcr1401 CrossRefPubMedPubMedCentral

Lund LR, Romer J, Thomasset N, Solberg H, Pyke C, Bissell MJ, Dano K, Werb Z (1996) Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development 122(1):181–193PubMedPubMedCentral

Marti A, Jehn B, Costello E, Keon N, Ke G, Martin F, Jaggi R (1994) Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells. Oncogene 9(4):1213–1223PubMed

Strange R, Li F, Saurer S, Burkhardt A, Friis RR (1992) Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development 115(1):49–58PubMed

Talhouk RS, Bissell MJ, Werb Z (1992) Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 118(5):1271–1282CrossRefPubMed

Walker NI, Bennett RE, Kerr JF (1989) Cell death by apoptosis during involution of the lactating breast in mice and rats. Am J Anat 185(1):19–32. doi:10.1002/aja.1001850104 CrossRefPubMed

10.

Lyons TR, O’Brien J, Borges VF, Conklin MW, Keely PJ, Eliceiri KW, Marusyk A, Tan AC, Schedin P (2011) Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 17(9):1109–1115. doi:10.1038/nm.2416 CrossRefPubMedPubMedCentral

11.

O’Brien J, Lyons T, Monks J, Lucia MS, Wilson RS, Hines L, Man YG, Borges V, Schedin P (2010) Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol 176(3):1241–1255. doi:10.2353/ajpath.2010.090735 CrossRefPubMedPubMedCentral

12.

Schedin P, O’Brien J, Rudolph M, Stein T, Borges V (2007) Microenvironment of the involuting mammary gland mediates mammary cancer progression. J Mammary Gland Biol Neoplasia 12(1):71–82. doi:10.1007/s10911-007-9039-3 CrossRefPubMed

13.

Radisky DC, Hartmann LC (2009) Mammary involution and breast cancer risk: transgenic models and clinical studies. J Mammary Gland Biol Neoplasia 14(2):181–191. doi:10.1007/s10911-009-9123-y CrossRefPubMedPubMedCentral

14.

Haricharan S, Li Y (2014) STAT signaling in mammary gland differentiation, cell survival and tumorigenesis. Mol Cell Endocrinol 382(1):560–569. doi:10.1016/j.mce.2013.03.014 CrossRefPubMed

15.

Watson CJ, Neoh K (2008) The Stat family of transcription factors have diverse roles in mammary gland development. Semin Cell Dev Biol 19(4):401–406. doi:10.1016/j.semcdb.2008.07.021 CrossRefPubMed

16.

Capuco AV, Ellis SE, Hale SA, Long E, Erdman RA, Zhao X, Paape MJ (2003) Lactation persistency: insights from mammary cell proliferation studies. J Anim Sci 81(Suppl 3):18–31CrossRefPubMed

17.

Bemis LT, Schedin P (2000) Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. Can Res 60(13):3414–3418

18.

Schedin P, Mitrenga T, McDaniel S, Kaeck M (2004) Mammary ECM composition and function are altered by reproductive state. Mol Carcinog 41(4):207–220. doi:10.1002/mc.20058 CrossRefPubMed

19.

Schedin P, Strange R, Mitrenga T, Wolfe P, Kaeck M (2000) Fibronectin fragments induce MMP activity in mouse mammary epithelial cells: evidence for a role in mammary tissue remodeling. J Cell Sci 113(Pt 5):795–806PubMed

20.

Kwaan HC, McMahon B (2009) The role of plasminogen-plasmin system in cancer. Cancer Treat Res 148:43–66. doi:10.1007/978-0-387-79962-9_4 CrossRefPubMed

21.

Lund LR, Bjorn SF, Sternlicht MD, Nielsen BS, Solberg H, Usher PA, Osterby R, Christensen IJ, Stephens RW, Bugge TH, Dano K, Werb Z (2000) Lactational competence and involution of the mouse mammary gland require plasminogen. Development 127(20):4481–4492PubMed

22.

Thomasset N, Lochter A, Sympson CJ, Lund LR, Williams DR, Behrendtsen O, Werb Z, Bissell MJ (1998) Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development. Am J Pathol 153(2):457–467. doi:10.1016/S0002-9440(10)65589-7 CrossRefPubMedPubMedCentral

23.

Hebbard L, Steffen A, Zawadzki V, Fieber C, Howells N, Moll J, Ponta H, Hofmann M, Sleeman J (2000) CD44 expression and regulation during mammary gland development and function. J Cell Sci 113(Pt 14):2619–2630PubMed

24.

Wagner KU, Boulanger CA, Henry MD, Sgagias M, Hennighausen L, Smith GH (2002) An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. Development 129(6):1377–1386PubMed

25.

Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ 3rd, Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353(3):229–237. doi:10.1056/NEJMoa044383 CrossRefPubMed

26.

Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312(3):146–151. doi:10.1056/NEJM198501173120303 CrossRefPubMed

27.

Radisky DC, Santisteban M, Berman HK, Gauthier ML, Frost MH, Reynolds CA, Vierkant RA, Pankratz VS, Visscher DW, Tlsty TD, Hartmann LC (2011) p16(INK4a) expression and breast cancer risk in women with atypical hyperplasia. Cancer Prev Res 4(12):1953–1960. doi:10.1158/1940-6207.CAPR-11-0282 CrossRef

28.

Ghaffarzadehgan K, Jafarzadeh M, Raziee HR, Sima HR, Esmaili-Shandiz E, Hosseinnezhad H, Taghizadeh-Kermani A, Moaven O, Bahrani M (2008) Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance. World J Gastroenterol 14(41):6376–6381CrossRefPubMedPubMedCentral

29.

Hastie T (1991) Generalized additive models. In: Chambers JH, Hastie TJ (ed) Statistical models in S. Chapman and Hall/CRC, Boca Raton, pp 250–309

30.

Geschickter C (1945) Diseases of the breast. J.B. Lipincott Co, Philadelphia

31.

Nguyen AV, Pollard JW (2000) Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. Development 127(14):3107–3118PubMed

32.

Kritikou EA, Sharkey A, Abell K, Came PJ, Anderson E, Clarkson RW, Watson CJ (2003) A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland. Development 130(15):3459–3468CrossRefPubMed

33.

Schere-Levy C, Buggiano V, Quaglino A, Gattelli A, Cirio MC, Piazzon I, Vanzulli S, Kordon EC (2003) Leukemia inhibitory factor induces apoptosis of the mammary epithelial cells and participates in mouse mammary gland involution. Exp Cell Res 282(1):35–47CrossRefPubMed

34.

Tiffen PG, Omidvar N, Marquez-Almuina N, Croston D, Watson CJ, Clarkson RW (2008) A dual role for oncostatin M signaling in the differentiation and death of mammary epithelial cells in vivo. Mol Endocrinol 22(12):2677–2688. doi:10.1210/me.2008-0097 CrossRefPubMedPubMedCentral

35.

Chapman RS, Lourenco PC, Tonner E, Flint DJ, Selbert S, Takeda K, Akira S, Clarke AR, Watson CJ (1999) Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev 13(19):2604–2616CrossRefPubMedPubMedCentral

36.

Humphreys RC, Bierie B, Zhao L, Raz R, Levy D, Hennighausen L (2002) Deletion of Stat3 blocks mammary gland involution and extends functional competence of the secretory epithelium in the absence of lactogenic stimuli. Endocrinology 143(9):3641–3650. doi:10.1210/en.2002-220224 CrossRefPubMed

37.

Chapman RS, Lourenco P, Tonner E, Flint D, Selbert S, Takeda K, Akira S, Clarke AR, Watson CJ (2000) The role of Stat3 in apoptosis and mammary gland involution. Conditional deletion of Stat3. Adv Exp Med Biol 480:129–138. doi:10.1007/0-306-46832-8_16 CrossRefPubMed

38.

Castellino FJ, Ploplis VA (2005) Structure and function of the plasminogen/plasmin system. Thromb Haemost 93(4):647–654. doi:10.1160/TH04-12-0842 PubMed

39.

Doeuvre L, Plawinski L, Goux D, Vivien D, Angles-Cano E (2010) Plasmin on adherent cells: from microvesiculation to apoptosis. Biochem J 432(2):365–373. doi:10.1042/BJ20100561 CrossRefPubMedPubMedCentral

40.

Reed JR, Schwertfeger KL (2010) Immune cell location and function during post-natal mammary gland development. J Mammary Gland Biol Neoplasia 15(3):329–339. doi:10.1007/s10911-010-9188-7 CrossRefPubMedPubMedCentral

41.

Martinson HA, Jindal S, Durand-Rougely C, Borges VF, Schedin P (2015) Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression. Int J Cancer 136(8):1803–1813. doi:10.1002/ijc.29181 CrossRefPubMed

42.

43.

O’Brien J, Martinson H, Durand-Rougely C, Schedin P (2012) Macrophages are crucial for epithelial cell death and adipocyte repopulation during mammary gland involution. Development 139(2):269–275. doi:10.1242/dev.071696 CrossRefPubMed

44.

O’Brien J, Schedin P (2009) Macrophages in breast cancer: do involution macrophages account for the poor prognosis of pregnancy-associated breast cancer? J Mammary Gland Biol Neoplasia 14(2):145–157. doi:10.1007/s10911-009-9118-8 CrossRefPubMedPubMedCentral

Title: Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution
Authors: Melody L. Stallings-Mann
Ethan P. Heinzen
Robert A. Vierkant
Stacey J. Winham
Tanya L. Hoskin
Lori A. Denison
Aziza Nassar
Lynn C. Hartmann
Daniel W. Visscher
Marlene H. Frost
Mark E. Sherman
Amy C. Degnim
Derek C. Radisky
Publication date: 01-11-2017
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 1/2017
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-017-4413-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2017

Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer

Erratum to: Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells

Functional importance of PP2A regulatory subunit loss in breast cancer

Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial

Fatty liver decreases the risk of liver metastasis in patients with breast cancer: a two-center cohort study

Analysis of molecular subtypes for the increased HER2 equivocal cases caused by application of the updated 2013 ASCO/CAP HER2 testing guidelines in breast cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer